SMARCA4 and non-small cell lung carcinoma: While SMARCA4 mutations are rarely identified in the presence of other BAF mutations or most targetable driver oncogenes [14, 16, 19], other alterations have been reported as highly prevalent in SMARCA4‐deficient NSCLC.